文献速递临床试验与 GCP基础与转化研究

L-ZIP研究:妊娠期叶黄素与玉米黄素补充对母婴眼部和全身类胡萝卜素状态的影响——随机对照试验方案

The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-04-22

L-ZIP是一项2期、单中心、前瞻性、双盲、随机活性对照临床试验,在犹他大学Moran眼科中心开展。孕妇每日服用不含类胡萝卜素的标准产前复合维生素,并按1:1随机分配至含10 mg叶黄素和2 mg玉米黄素的红花油胶囊组(类胡萝卜素组)或仅含红花油的胶囊组(对照组),持续6至8个月。研究主要结局是妊娠期间母体全身和眼部类胡萝卜素状态的变化,并评估婴儿黄斑色素和中心凹解剖结构。

要点

  • 孕期类胡萝卜素补充可能抵消母体类胡萝卜素耗竭。
  • 研究采用皮肤反射共振拉曼光谱、血清HPLC和黄斑色素双波长自荧光测量。
  • 婴儿黄斑色素和中心凹解剖分别用RetCam视网膜相机和Bioptigen SD-OCT评估。

核心结论

  • L-ZIP是首个探讨妊娠期母体类胡萝卜素状态及产前补充能否抵消母体类胡萝卜素耗竭并改善母婴类胡萝卜素状态生物标志物的前瞻性随机对照试验。

研究设计与样本

  • 2期、单中心、前瞻性、双盲、随机活性对照临床试验,在犹他大学Moran眼科中心开展。
  • 孕妇每日服用不含类胡萝卜素的标准产前复合维生素,按1:1随机分配至类胡萝卜素组(10 mg叶黄素和2 mg玉米黄素,红花油胶囊)或对照组(仅红花油胶囊),持续6至8个月。
  • 在妊娠早期(基线)、中期、晚期及产后0-2周测量皮肤、血清和眼部类胡萝卜素。

关键数值与推荐

  • 类胡萝卜素组每日补充10 mg叶黄素和2 mg玉米黄素。
  • 皮肤类胡萝卜素评估采用反射共振拉曼光谱(RRS)。
  • 血清类胡萝卜素状态采用高效液相色谱(HPLC)定量。
  • 黄斑色素(MP)采用双波长自荧光测量。
  • 婴儿黄斑色素和中心凹解剖分别采用RetCam视网膜相机和Bioptigen SD-OCT评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ), collectively called the macular pigment (MP), are dietary carotenoids that preferentially localize in the macula of the human eye. MP protects the macula from photo-oxidative damage and enhances visual function. Inadequate maternal intake of carotenoids, coupled with the placental transfer of maternal carotenoids to support fetal brain and retina development, potentially put mothers at risk of depletion systemically and in their ocular tissues. Presently, maternal carotenoid status throughout pregnancy remains poorly characterized, and no prospective randomized controlled trial of L and Z supplementation via prenatal vitamins has assessed maternal and infants' systemic and ocular carotenoid status during pregnancy. We hypothesize that prenatal maternal carotenoid supplementation will counteract maternal carotenoid depletion during pregnancy and will improve biomarkers of carotenoid status of both mothers and infants. METHODS: Lutein and Zeaxanthin in Pregnancy (L-ZIP) is a phase 2, single-center, prospective, double-masked, randomized active-controlled clinical trial conducted at the John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA. Participants consume a daily standard prenatal multivitamin with no added carotenoids and are randomized (1:1 allocation) to receive either a capsule containing 10 mg L and 2 mg Z in safflower oil (Carotenoid group) or a capsule containing only safflower oil with no added carotenoids (Control group) for a period of 6 to 8 months. Skin, serum, and ocular carotenoids are measured at every study visit (i.e., within the first trimester [baseline], second trimester, third trimester, and 0-2 weeks postpartum). Skin carotenoid assessment is by resonance Raman spectroscopy (RRS); serum carotenoid status is quantified using high-performance liquid chromatography (HPLC); and MP is measured with the dual-wavelength autofluorescence. Infants' MP and foveal anatomy are assessed using RetCam retinal camera and Bioptigen SD-OCT, respectively. The primary outcomes are changes in maternal systemic and ocular carotenoid status during pregnancy. DISCUSSION: L-ZIP is the first prospective RCT to investigate maternal carotenoid status throughout pregnancy and to determine whether prenatal maternal carotenoid supplementation will offset maternal carotenoid depletion and improve biomarkers of maternal and infant's carotenoid status. Findings from L-ZIP will strengthen recommendations regarding prenatal carotenoid supplementation and consequently inform policy decisions. TRIAL REGISTRATION: ClinicalTrials.gov NCT03750968 . Registered on November 23, 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Addo EK, Gorusupudi A, Allman S, et al. The Lutein and Zeaxanthin in Pregnancy (L-ZIP) study-carotenoid supplementation during pregnancy: ocular and systemic effects-study protocol for a randomized controlled trial. Trials. 2021. PMID: 33888136. doi:10.1186/s13063-021-05244-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。